The Baltimore Biologics Drug Substance facility will serve customers across human and animal health market segments.

This collective initiative aims to advance India’s CRDMO sector and is dedicated to fostering pharmaceutical and healthcare ...

The Noramco Group is investing $25M into its Halo Pharma facility in Whippany, NJ to establish sterile injectable ...

The transaction provides Curia with incremental capital and extends the maturities of its secured credit facilities.

Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, has earned a committed badge from ...

Azelis, a service provider in the specialty chemicals and food ingredients industry, has been appointed exclusive distributor ...

Aragen, a global Contract Research, Development and Manufacturing Organization (CRDMO), has made two senior level ...

The FDA has approved Celltrion’s OMLYCLO (omalizumab-igec) as the first and only biosimilar designated as interchangeable ...

In today’s evolving pharmaceutical environment, the fill‐finish segment stands out as a critical linchpin connecting drug ...

In the evolving landscape of pharmaceutical production, fill-finish contract manufacturing has become a crucial area of focus ...

Significant growth in demand for pharmaceuticals, such as GLP-1s, increased R&D spending for autonomous manufacturing, and ...

Exploring Regulatory Affairs, the discipline dedicated to ensuring that new drugs and biologics are safe, effective, and ...